Much of the discussion to date regarding price gouging laws has rightly focused on the two core elements of a price gouging lawsuit: what constitutes a violation and what are the defenses? And while these defenses are valid, most would prefer to never have to spend the time and expense getting a case dismissed in the first place – raising the question of whether a declaratory judgment may be the right solution.

A declaratory judgment allows a court to define the relationship between parties where there is an “actual controversy” between the parties at or before the filing of the suit. Declaratory judgments are creatures of statute, and both the federal government and most states have a form of declaratory judgement. While declaratory judgments cannot be used to seek an opinion advising what the law would be on a hypothetical set of facts, this does not mean that plaintiffs need wait for liability in order to bring a declaratory judgment action. Indeed a chief purpose of a declaratory judgment action is to define one’s rights before they are violated.

In the price gouging context, a declaratory judgment action would likely challenge a price gouging law in one of two ways: by arguing that the law or its application was unconstitutional or otherwise invalid. Under either scenario, a party would potentially be able to affirmatively bring suit to determine whether its conduct was prohibited, without having to wait for a lawsuit.

Declaratory actions are often used by plaintiffs to challenge laws they find unconstitutional. In 2018, for example, the Sixth Circuit held that a district court properly ruled that Tennessee’s durational-residency requirement for retail alcohol licenses was unconstitutional in violation of the Dormant Commerce Clause. The suit arose when two non-Tennessee companies applied for retail alcohol licenses, prompting Tennessee’s Attorney General to bring a declaratory judgment action seeking to construe the constitutionality of the durational-residency requirement.

While this may potentially provide a path to avoiding price gouging liability with a declaratory judgment action, questions remain. The first is standing, a legal concept that limits who may bring a suit to those that have actually been harmed by the offending conduct in question. Generally, in order to have standing, a plaintiff must show that it suffered an injury, that there is a causal connection between the defendant’s conduct and the plaintiff’s injury, and that it is likely that the injury would be redressed by the court’s decision.

Where there exists only the specter of a suit, but not a sufficiently definite threat of one actually occurring, a declaratory judgment may not always be appropriate. However, standing may potentially or arguably arise for instance, where a company is foreclosed from engaging in normal course of business pricing practices as a result of an extended state of emergency declaration and attendant pricing restrictions. Similarly, where a company is the subject of a government investigation or private lawsuit – the question of standing will be easily decided in the affirmative. Even if there is standing, a court may nevertheless view the question as unresolvable at the declaratory judgment stage if it involves questions of fact. This could be particularly so in the price gouging context where a company’s pricing decisions may be the result of a complex process. Proving that such complicated pricing decisions were or were not caused by some other (or many other) set of facts may be just the type of investigation that a judge would find appropriate to let play out in discovery.

Businesses should consider whether, in the appropriate circumstances, they may be able to head off a significant expense, or even ultimate liability, with a well-constructed declaratory judgment action. As price gouging law develops, it is important for companies to remain agile and consider all options to avoid price gouging lawsuits.

*      *      *

Visit Proskauer on Price Gouging for antitrust insights on COVID-19.

*      *      *

Proskauer’s cross-disciplinary, cross-jurisdictional Coronavirus Response Team is focused on supporting and addressing client concerns. Visit our Coronavirus Resource Center for guidance on risk management measures, practical steps businesses can take and resources to help manage ongoing operations.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Kelly Landers Hawthorne Kelly Landers Hawthorne

Kelly Landers Hawthorne is an associate in the Litigation Department and a member of the Antitrust and Product Liability groups. She represents clients in litigations and due diligence across a range of industries, including consumer products, life sciences, healthcare, education, hospitality, sports and…

Kelly Landers Hawthorne is an associate in the Litigation Department and a member of the Antitrust and Product Liability groups. She represents clients in litigations and due diligence across a range of industries, including consumer products, life sciences, healthcare, education, hospitality, sports and entertainment.

Kelly also maintains a diverse pro bono practice. She received Proskauer’s Golden Gavel Award for excellence in pro bono work in 2019.

She is a frequent contributor to Proskauer’s Minding Your Business blog, where she authors articles related to price gouging issues.

Kelly is also a member of the Proskauer Women’s Alliance Steering Committee, where she serves on subcommittees focused on highlighting and providing professional development opportunities for women at the firm.

Prior to her legal career, Kelly was a Teach For America corps member and taught middle school in Washington, DC.

While at Columbia Law School, Kelly served as an articles editor of the Columbia Journal of Law & the Arts and interned for the Honorable Sandra Townes of the U.S. District Court for the Eastern District of New York.

Photo of John R. Ingrassia John R. Ingrassia

John is a partner at the Firm, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating…

John is a partner at the Firm, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating to competition and antitrust, CFIUS or foreign investment issues.

For more than 25 years, John has counselled businesses facing the most challenging antitrust issues and helped them stay out of the crosshairs — whether its distribution, pricing, channel management, mergers, acquisitions, joint ventures, or price gouging compliance.

John’s practice focuses on the analysis and resolution of CFIUS and antitrust issues related to mergers, acquisitions, and joint ventures, and the analysis and assessment of pre-merger CFIUS and HSR notification requirements. He advises clients on issues related to CFIUS national security reviews, and on CFIUS submissions when non-U.S. buyers seek to acquire U.S. businesses that have national security sensitivities.  He also regularly advises clients on international antitrust issues arising in proposed acquisitions and joint ventures, including reportability under the EC Merger Regulation and numerous other foreign merger control regimes.

His knowledge, reputation and extensive experience with the legal, practical, and technical requirements of merger clearance make him a recognized authority on Hart-Scott-Rodino antitrust merger review. John is regularly invited to participate in Federal Trade Commission and bar association meetings and takes on the issues of the day.

Photo of Christopher E. Ondeck Christopher E. Ondeck

Chris Ondeck is co-chair of the Firm’s Antitrust Group and co-head of the Washington DC office. He represents clients in complex antitrust and consumer protection litigation, defends mergers and acquisitions before the U.S. antitrust agencies, represents companies involved in government investigations, and counsels…

Chris Ondeck is co-chair of the Firm’s Antitrust Group and co-head of the Washington DC office. He represents clients in complex antitrust and consumer protection litigation, defends mergers and acquisitions before the U.S. antitrust agencies, represents companies involved in government investigations, and counsels on antitrust compliance. Chris is also the founder and leader of the firm’s Price Gouging Practice, and is one of the key thought leaders in this space.

Chris handles antitrust matters for clients in a number of industries, including food and agriculture, financial services, media, telecom, technology, e-commerce, consumer products, natural resources, oil and gas, chemicals, and pharmaceuticals.  He also serves as outside counsel to a large number of industry groups, including trade associations and cooperatives.

Chris has been recognized as a leading antitrust practitioner by Chambers, noting that clients describe him as “our primary thought partner – he’s very good at explaining the complex issues and making them easy to understand” and praising “his strong advocacy skills”; by The National Law Review as a “Go To Thought Leader 2020”; by Acritas as a “Star” in multiple years; by Benchmark Litigation as a National Litigation Star 2021; and by The Legal 500 United States for Antitrust: Civil Litigation/Class Actions.